<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>生物制药小编 | wechat-feeds</title><link>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</link><description>“新起点，再出发”——生物医药小编与您共同关注生物制药行业热点。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 08 Apr 2021 10:15:53 +0800</pubDate><image><url>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</url><title>生物制药小编 | wechat-feeds</title><link>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>报名开启 | 2021PVcon生物制品安全与工艺大会</title><link>https://mp.weixin.qq.com/s/REm7_utUtny5j7rTIeMiWQ</link><description></description><content:encoded><![CDATA[报名开启 | 2021PVcon生物制品安全与工艺大会]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:24:22 +0800</pubDate></item><item><title>聚焦抗体改造，把握毒理/药代脉搏</title><link>https://mp.weixin.qq.com/s/JMWj8jhQG0_uUnEe3BsVow</link><description></description><content:encoded><![CDATA[聚焦抗体改造，把握毒理/药代脉搏]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:24:22 +0800</pubDate></item><item><title>参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！</title><link>https://mp.weixin.qq.com/s/8Jst-hcVOQc2yN0pooeKnw</link><description></description><content:encoded><![CDATA[参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！]]></content:encoded><pubDate>Wed, 07 Apr 2021 17:24:22 +0800</pubDate></item><item><title>Abecma刚获批上市，BMS/蓝鸟发文阐述BCMA CAR-T耐药机制</title><link>https://mp.weixin.qq.com/s/FtjKUHrA5i0EEf3M6-D9IQ</link><description></description><content:encoded><![CDATA[Abecma刚获批上市，BMS/蓝鸟发文阐述BCMA CAR-T耐药机制]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:18:18 +0800</pubDate></item><item><title>参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！</title><link>https://mp.weixin.qq.com/s/DuOKGAFtfv-eDZ7l9-ZDIA</link><description></description><content:encoded><![CDATA[参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:18:18 +0800</pubDate></item><item><title>未来可期| 北大生物成功取得《药品生产许可证》</title><link>https://mp.weixin.qq.com/s/PlCkHvbozotVbEJ0NWH5Aw</link><description></description><content:encoded><![CDATA[未来可期| 北大生物成功取得《药品生产许可证》]]></content:encoded><pubDate>Mon, 05 Apr 2021 17:53:16 +0800</pubDate></item><item><title>今晚7：00| 智能自动注射装置将引发新一轮的药企竞争浪潮</title><link>https://mp.weixin.qq.com/s/q1W6fkFMeOH_C3mUa-eByQ</link><description></description><content:encoded><![CDATA[今晚7：00| 智能自动注射装置将引发新一轮的药企竞争浪潮]]></content:encoded><pubDate>Mon, 05 Apr 2021 17:53:16 +0800</pubDate></item><item><title>参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！</title><link>https://mp.weixin.qq.com/s/664Dcz9HWNv-Rq9z-z5JZw</link><description></description><content:encoded><![CDATA[参会须知 | 4月9日参会必备，TG-Bio大会精彩内容即将开启！]]></content:encoded><pubDate>Mon, 05 Apr 2021 17:53:16 +0800</pubDate></item><item><title>CAR-T的不良反应和应对方法</title><link>https://mp.weixin.qq.com/s/eOQI7lCMfkEXYbtC9M0Ikw</link><description></description><content:encoded><![CDATA[CAR-T的不良反应和应对方法]]></content:encoded><pubDate>Sun, 04 Apr 2021 22:07:36 +0800</pubDate></item><item><title>免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析</title><link>https://mp.weixin.qq.com/s/8Bgv3fx7nhY2tZ9GUNOf4w</link><description></description><content:encoded><![CDATA[免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析]]></content:encoded><pubDate>Sun, 04 Apr 2021 22:07:36 +0800</pubDate></item><item><title>酸性pH值：肿瘤微环境特点及生物技术药物开发</title><link>https://mp.weixin.qq.com/s/S8095oZzjepnu8IIby_7oQ</link><description></description><content:encoded><![CDATA[酸性pH值：肿瘤微环境特点及生物技术药物开发]]></content:encoded><pubDate>Sat, 03 Apr 2021 20:18:08 +0800</pubDate></item><item><title>免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析</title><link>https://mp.weixin.qq.com/s/5NojO1xq18h750xu-lRj6A</link><description></description><content:encoded><![CDATA[免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析]]></content:encoded><pubDate>Sat, 03 Apr 2021 20:18:08 +0800</pubDate></item><item><title>做中国生物医药的忠实记录者</title><link>https://mp.weixin.qq.com/s/23Iu8fTixfg_lUCKBC5QBA</link><description></description><content:encoded><![CDATA[做中国生物医药的忠实记录者]]></content:encoded><pubDate>Sat, 03 Apr 2021 20:18:08 +0800</pubDate></item><item><title>巨噬细胞：肿瘤免疫治疗的新热点</title><link>https://mp.weixin.qq.com/s/MSDyRQIqlO0AaIdcZzvbQA</link><description></description><content:encoded><![CDATA[巨噬细胞：肿瘤免疫治疗的新热点]]></content:encoded><pubDate>Sat, 03 Apr 2021 09:00:23 +0800</pubDate></item><item><title>热烈祝贺！邦耀生物任命高杨博士为高级副总裁&amp;首席战略官</title><link>https://mp.weixin.qq.com/s/ZIUd53xRTkIc5414VQB-Pw</link><description></description><content:encoded><![CDATA[热烈祝贺！邦耀生物任命高杨博士为高级副总裁&首席战略官]]></content:encoded><pubDate>Sat, 03 Apr 2021 09:00:23 +0800</pubDate></item><item><title>免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析</title><link>https://mp.weixin.qq.com/s/2fcO3lNNqva9b98fNilPtQ</link><description></description><content:encoded><![CDATA[免疫治疗的商业化生产解决方案-GMP、CMC及平台选择解析]]></content:encoded><pubDate>Sat, 03 Apr 2021 09:00:23 +0800</pubDate></item><item><title>居家注射时代开启！掀起未来药企新赛道竞争浪潮</title><link>https://mp.weixin.qq.com/s/tyMffy-ZJft66R1QoH-62A</link><description></description><content:encoded><![CDATA[居家注射时代开启！掀起未来药企新赛道竞争浪潮]]></content:encoded><pubDate>Fri, 02 Apr 2021 07:19:41 +0800</pubDate></item><item><title>连续失利“T+D”方案，肝癌疗效可期，能助AZ一局？</title><link>https://mp.weixin.qq.com/s/FPndxOuqQgLG-Ng3IYumnQ</link><description></description><content:encoded><![CDATA[连续失利“T+D”方案，肝癌疗效可期，能助AZ一局？]]></content:encoded><pubDate>Fri, 02 Apr 2021 07:19:41 +0800</pubDate></item><item><title>一文读不懂免疫治疗？“一会”可以！</title><link>https://mp.weixin.qq.com/s/MPtPlbdLL-wlCLhWrVThFg</link><description></description><content:encoded><![CDATA[一文读不懂免疫治疗？“一会”可以！]]></content:encoded><pubDate>Fri, 02 Apr 2021 07:19:41 +0800</pubDate></item><item><title>相同信号、不同命运，CD28 CAR-T和4-1BB CAR-T的差异根源</title><link>https://mp.weixin.qq.com/s/SchewSpqhmQ8bkgYNkfdJw</link><description></description><content:encoded><![CDATA[相同信号、不同命运，CD28 CAR-T和4-1BB CAR-T的差异根源]]></content:encoded><pubDate>Wed, 31 Mar 2021 19:04:42 +0800</pubDate></item></channel></rss>